APTAMER GROUP PLC ORD 0.1P吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
25 0 公告 Aptamer Announces New Data at ASGCT APTAMER GROUP PL资讯 05-15 14:38
21 0 公告 Optimer licensing agreements and repeat contracts APTAMER GROUP PL资讯 05-15 14:18
24 0 公告 Alzheimer’s test advanced and royalty agreement APTAMER GROUP PL资讯 05-06 14:44
30 0 公告 Licensing agreed for Optimer as vaccine adjuvant APTAMER GROUP PL资讯 04-30 15:04
27 0 公告 Aptamer Presenting at ASGCT Annual Meeting APTAMER GROUP PL资讯 04-29 14:14
22 0 公告 New Corporate Presentation and Investor Factsheet APTAMER GROUP PL资讯 04-24 14:14
28 0 公告 Interim Results APTAMER GROUP PL资讯 03-11 15:26
21 0 公告 TR-1: Standard form notification of major holdings APTAMER GROUP PL资讯 02-27 20:53
27 0 公告 Block Listing Interim Review APTAMER GROUP PL资讯 02-25 16:30
26 0 公告 Notice of Results and Investor Presentation APTAMER GROUP PL资讯 02-25 15:24
36 0 公告 Issue of Equity in lieu of Director fees APTAMER GROUP PL资讯 01-28 22:58
39 0 公告 Half Year Trading Update APTAMER GROUP PL资讯 01-28 15:09
37 0 公告 Notification of dealings by a director/PDMR APTAMER GROUP PL资讯 01-13 19:43
53 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 12-30 15:08
70 0 公告 Notification of dealings by a director/PDMR APTAMER GROUP PL资讯 12-20 00:47
72 0 公告 New Development Contract APTAMER GROUP PL资讯 12-19 15:16
57 0 公告 TR-1: Standard form notification of major holdings APTAMER GROUP PL资讯 12-18 18:56
58 0 公告 Notification of dealings by a director/PDMR APTAMER GROUP PL资讯 12-16 19:31
59 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 12-12 15:58
52 0 公告 Notification of dealings by a director/PDMR APTAMER GROUP PL资讯 12-09 23:34
57 0 公告 Notification of dealings by a director/PDMR APTAMER GROUP PL资讯 12-09 21:52
60 0 公告 Grant of Options and Director Fee Shares APTAMER GROUP PL资讯 12-09 15:17
63 0 公告 New Scientific Advisory Board Members APTAMER GROUP PL资讯 12-06 15:12
63 0 公告 Technical Update APTAMER GROUP PL资讯 12-05 15:15
60 0 公告 Investor Webinar APTAMER GROUP PL资讯 12-04 15:16
61 0 公告 Results of 2024 Annual General Meeting APTAMER GROUP PL资讯 11-29 19:08
57 0 公告 AGM Statement APTAMER GROUP PL资讯 11-29 15:14
62 0 公告 Agreement extended with genetic medicines customer APTAMER GROUP PL资讯 11-07 15:47
53 0 公告 Commercial Trading Update APTAMER GROUP PL资讯 11-06 15:15
64 0 公告 Posting of Annual Report and Notice of AGM APTAMER GROUP PL资讯 11-05 15:52
58 0 公告 Full Year Results for the 12mths to 30 June 2024 APTAMER GROUP PL资讯 10-22 14:15
71 0 公告 Notice of Results and Investor Presentation APTAMER GROUP PL资讯 10-17 14:16
58 0 公告 Director Appointment APTAMER GROUP PL资讯 09-16 14:19
44 0 公告 Aptamer extends contract with Unilever APTAMER GROUP PL资讯 09-03 14:11
50 0 公告 Block listing Interim Review APTAMER GROUP PL资讯 08-27 15:09
51 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 08-20 22:32
57 0 公告 TR-1: Standard form notification of major holdings APTAMER GROUP PL资讯 08-16 21:12
53 0 公告 TR-1: Standard form notification of major holdings APTAMER GROUP PL资讯 08-14 19:37
53 0 公告 Result of General Meeting and Board Changes APTAMER GROUP PL资讯 08-13 21:03
51 0 公告 Supplementary Conditional Placing for £60,000 APTAMER GROUP PL资讯 08-02 00:42
54 0 公告 Posting of Circular and Notice of General Meeting APTAMER GROUP PL资讯 07-25 02:18
55 0 公告 Fundraise to Raise £2.83 million APTAMER GROUP PL资讯 07-24 20:42
59 0 公告 Trading Update APTAMER GROUP PL资讯 07-08 15:32
64 0 公告 Update on progress in Unilever partnership APTAMER GROUP PL资讯 07-08 15:31
68 0 公告 Agreement to explore Optimer vehicles for siRNA APTAMER GROUP PL资讯 07-03 15:15
57 0 公告 New Contracts Announcement for Optimer Development APTAMER GROUP PL资讯 06-24 15:11
63 0 公告 Partnership with Microsaic Systems APTAMER GROUP PL资讯 06-14 15:07
61 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 06-01 00:12
62 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 05-28 17:12
57 0 公告 New contracts with top ten pharma partners APTAMER GROUP PL资讯 05-23 15:07
56 0 公告 Aptamer and Timser Partnership APTAMER GROUP PL资讯 05-22 15:12
50 0 公告 Trading Update APTAMER GROUP PL资讯 05-13 15:53
51 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 04-25 23:52
53 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 04-24 16:52
48 0 公告 Holding(s) in Company - REPLACEMENT APTAMER GROUP PL资讯 04-23 22:08
49 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 04-23 00:47
52 0 公告 Top Pharma Company evaluates Optimer for medicine APTAMER GROUP PL资讯 04-22 15:08
60 0 公告 TR-1: Notification of major holdings APTAMER GROUP PL资讯 04-18 18:13
51 0 公告 Aptamer and Kairos Biotech partner for Optimer+ APTAMER GROUP PL资讯 04-18 15:12
52 0 公告 Patent submission for Optimer binders APTAMER GROUP PL资讯 04-08 15:08
48 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 03-28 23:13
46 0 公告 Interim Results APTAMER GROUP PL资讯 03-28 16:04
52 0 公告 Notice of Interim Results & Investor Presentation APTAMER GROUP PL资讯 03-22 16:08
58 0 公告 Investor Webinar APTAMER GROUP PL资讯 03-14 16:08
58 0 公告 Aptamer Progresses Partnership with Unilever APTAMER GROUP PL资讯 03-11 16:08
73 0 公告 Block Listing Interim Review APTAMER GROUP PL资讯 02-29 16:08
64 0 公告 R&D progress on new Optimer+ platform APTAMER GROUP PL资讯 02-27 16:08
62 0 公告 Second Phase of Alzheimer's test with Neuro-Bio APTAMER GROUP PL资讯 02-22 16:08
90 0 公告 Half Year Trading Update APTAMER GROUP PL资讯 02-05 17:25
67 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 01-04 23:42
77 0 公告 Results of 2023 Annual General Meeting APTAMER GROUP PL资讯 12-16 01:09
97 0 公告 AGM Statement APTAMER GROUP PL资讯 12-15 16:12
93 0 公告 Material Agreement with Genetic Medicines Company APTAMER GROUP PL资讯 12-14 16:10
71 0 公告 Posting of Annual Report and Notice of AGM APTAMER GROUP PL资讯 11-20 16:10
59 0 公告 Full year results for the 12mths ended 30 Jun 2023 APTAMER GROUP PL资讯 11-09 16:43
80 0 公告 Notice of Results and Investor Presentation APTAMER GROUP PL资讯 11-08 21:34
71 0 公告 Trading Update APTAMER GROUP PL资讯 11-06 16:08
83 0 公告 Holding(s) in Company APTAMER GROUP PL资讯 10-24 19:01
78 0 公告 Grant of Options and Related Party Transaction APTAMER GROUP PL资讯 10-09 17:48
84 0 公告 Placing and Subscription, PDMR Dealing and TVR APTAMER GROUP PL资讯 09-19 22:42
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
郑重声明:用户在社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500